Tevogen Founder and CEO Dr. Ryan Saadi recently donated 10,000 shares of his personal stock in the company to the Opportunity Project, a nonprofit leader in caring for those with brain injuries.
The gift is another example of how Tevogen, a clinical-stage specialty immunotherapy company headquartered in Warren, aims to give back to others in the health care sector.
“This donation is a small way to express my admiration for Opportunity Project’s work and its impact on so many lives,” Saadi said. “As a fellow New Jersey organization, we share a deep commitment to supporting our community and advancing human potential.”
For more than 30 years, Opportunity Project has provided adults who have sustained a brain injury with opportunities to build cognitive skills, vocational skills and confidence in their ability to accomplish personal goals and lead fulfilling lives. In addition, Opportunity Project leads regional and national awareness initiatives for communities, schools and corporations.
Kerri Berson Levine, chair of the Opportunity Project’s Board of Trustees, said the group was deeply grateful.
“Contributions like this help ensure the ongoing success of Opportunity Project and our innovative Clubhouse program while guaranteeing that no individual with a brain injury is ever turned away due to an inability to pay,” she said. “Our critical work would not be possible without the dedication of our donors and community partners.”
Opportunity Project was established after Levine’s brother Gary — son of founding trustees Marc Berson and Rita Yohalem — almost lost his life in a serious auto accident and after founding trustee Lisa Goldman’s son Danny was forever changed by a brain tumor.
Donor contributions such as Saadi’s support a wide range of programs, including occupational therapy promoting independent living, nutrition and wellness initiatives, mental health workshops, member-to-member mentoring and a Caregivers’ Group that provides essential support to members and their families.
